Paul Hartmann AG (STU:PHH2) Total Equity: €1,222 Mil (As of Dec. 2025)

What is Paul Hartmann AG Total Equity?

Paul Hartmann AG STU:PHH2 61 Total Equity is €1,222 Mil as of Dec. 2025. GuruFocus rates STU:PHH2 with a GF Score™ of 61/100 and a GF Value™ of €225.24 (Fairly Valued). The stock has 4 warning signs investors should review.

Paul Hartmann AG's total equity for the quarter that ended in Dec. 2025 was €1,222 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Paul Hartmann AG Total Equity Related Terms

Paul Hartmann AG Total Equity Historical Data

* Premium members only.

The historical data trend for Paul Hartmann AG's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Paul Hartmann AG Total Equity Chart

Paul Hartmann AG Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Equity

Get a 7-Day Free Trial

1,093.00

1,128.66

1,115.55

1,196.07

1,222.36

Paul Hartmann AG Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Total Equity	Get a 7-Day Free Trial															1,115.55	1,130.33	1,196.07	1,172.26	1,222.36

61GF Score

Paul Hartmann AG STU:PHH2

Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Paul Hartmann AG Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Paul Hartmann AG's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2025 )	-	Total Liabilities(Q: Dec. 2025 )
	=	2161.147	-	938.788
	=	1,222

Paul Hartmann AG's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2025 )	-	Total Liabilities(Q: Dec. 2025 )
	=	2161.147	-	938.788
	=	1,222

Frequently Asked Questions Learn more about Total Equity →

What does a Total Equity of €1,222 Mil mean?

Paul Hartmann AG (STU:PHH2) has a Total Equity of €1,222 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Paul Hartmann AG and its competitors.

Is Paul Hartmann AG's Total Equity too high?

Paul Hartmann AG's current Total Equity is €1,222 Mil. Overall, Paul Hartmann AG has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Paul Hartmann AG's Total Equity compare to ISRG and BDX?

Paul Hartmann AG's Total Equity of €1,222 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Equity for a Medical Devices & Instruments company?

A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Equity mean?

A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Paul Hartmann AG and its competitors. Paul Hartmann AG's current Total Equity is €1,222 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Paul Hartmann AG stock overvalued right now?

Based on GuruFocus' analysis, Paul Hartmann AG (STU:PHH2) is currently considered Fairly Valued. The stock's GF Value™ is €225.24, compared to a current price of €204.00 — trading 9.4% below its estimated fair value. The current Total Equity is €1,222 Mil. Paul Hartmann AG's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Equity calculated?

Total Equity is calculated from a company's financial statements. For Paul Hartmann AG (STU:PHH2), the current Total Equity is €1,222 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Paul Hartmann AG (STU:PHH2) Overvalued in 2026?

Based on GuruFocus' analysis, Paul Hartmann AG stock appears to be undervalued. The current stock price of €204.00 is trading 9.4% below its estimated GF Value™ of €225.24. GuruFocus considers Paul Hartmann AG to be Fairly Valued.

Key valuation signals for STU:PHH2:

Total Equity: €1,222 Mil
GF Value™: €225.24 vs. price of €204.00 (9.4% below fair value)
GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the STU:PHH2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Paul Hartmann AG Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies XTER:GXI XTER:AFX XTER:1SXP ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST XSWX:STMN TSE:4543 XPAR:DIM COO SOLV OCSE:COLO B NZSE:FPH ALGN BAX

Other Exchanges PHH2:Germany

Address Paul-Hartmann-Strasse 12, Heidenheim, DEU, 89522

Website http://www.hartmann.info

Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.

61GF Score

Get the complete analysis for STU:PHH2

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€204.00

Price

€225.24

GF Value

View STU:PHH2 Analysis

See Total Equity data for all stocks →